市場調查報告書
商品編碼
1245681
全球分析儀器市場規模、份額、行業趨勢分析報告:按產品(儀器、軟件、服務)、技術、應用、地區、展望和預測,2022-2028 年Global Analytical Instrumentation Market Size, Share & Industry Trends Analysis Report By Product (Instruments, Software and Services), By Technology, By Application, By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,全球分析儀器市場規模預計將達到 664 億美元,預測期內復合年增長率為 4.0%。
公司也在開發創新技術並開發未開發的市場潛力,以滿足不斷增長的需求,這是由分析儀器的技術進步推動的。此外,隨著精準醫學的進步,分析儀器解決方案的使用有望增加。為了識別疾病和創建定制治療,精準醫學利用分析儀器進行下一代測序、分子成像、分子動力學和分子診斷。
例如,在分子診斷學中,進行基因組測序以分析患者的生物標誌物。使用各種分析工具執行此類測試還可以提供有關最佳治療過程的知識,甚至可以為特定患者預測最合適的治療方法。此外,在藥物開發過程中,顯微鏡和冷凍電子顯微鏡等技術被廣泛用於研究蛋白質等生物體的三維結構。
COVID-19 影響分析
由於COVID-19大流行,熱分析儀、光譜儀和色譜相關儀器等分析儀器業務已經收縮。這是由於嚴格法規的實施、供應鏈的中斷以及同時臨床試驗的減少。但受疫情影響,2021年PCR、芯片、測序儀技術相關設備需求大幅增加。在此期間,已經推出了幾種新的 PCR 產品,以滿足越來越多的 COVID-19 病例。伴隨著產品需求的不平衡,出現了產品交付延遲等問題,阻礙了分析儀器行業的供應鏈。
市場增長因素
高精尖醫學發展突飛猛進
為此,正在推動精準診療方法的發展,以及下一代測序(NGS)和大規模基因組數據的發展。此外,在基因治療和開髮用於治療癌症、肺結核和阿爾茨海默病等疾病的精準藥物方面也取得了重大進展。因此,越來越多的製藥和生物技術公司開始進入這個市場。因此,分析儀器市場的增長受到精準醫療的推動,精準醫療提供個性化的藥物和治療。
在水和廢水處理中越來越多地使用分析儀器
水和廢水中存在色譜法等許多過程。因此,色譜領域的發展離不開大數據、人工智能等前沿技術的融合。鑑於色譜分析過程中產生的大量數據,此類技術有望實現數據分類自動化並提高定量結果的可信度。因此,各種研發活動對分析儀器的需求,主要用於評估水和廢水處理的特性和參數,正在推動市場增長。
市場製約因素
缺乏熟練的專業人員來操作分析儀器
隨著技術的進步,分析儀器變得越來越複雜,需要熟練的工作人員有效地處理它們。另一個主要障礙是缺乏建立測試設施的基礎設施。由於製造業分散且通常規模較小,因此在許多發展中國家很難從這些公司中抽樣。缺乏機構合作和設備不足是另外兩個關鍵問題。因此,合格專業人員的短缺將限制最終用戶對測試設備和耗材的採用,從而減緩市場增長。
產品前景
基於產品,分析儀器市場分為儀器、服務和軟件。2021年的分析儀器市場,軟件板塊獲得了可觀的增速。在學術研究和臨床診斷等各種環境下的分析工作中,軟件經常用於數據處理和結果解釋。例如,借助流式細胞儀軟件進行數據採集和控制,然後對結果進行統計分析。預計此類軟件功能將在預測期內推動該細分市場的擴張。
技術展望
按技術劃分,分析儀器市場分為聚合□鏈反應、光譜學、顯微鏡、色譜、流式細胞術、測序儀、微陣列等。2021 年,色譜部門在分析儀器市場中佔據了重要的收入份額。生命科學、製藥等領域的多樣化應用是該細分市場崛起的主要原因。色譜的三種類型是氣相色譜、液相色譜和離子色譜。複雜的蛋白質組學研究是使用液相色譜法發現的。離子色譜用於需要質量控制的領域,例如環境檢測。
應用前景
根據應用,分析儀器市場分為生命科學研發、臨床和診斷分析、食品和飲料分析、法醫分析、環境測試等。2021 年,臨床和診斷分析部門在分析儀器市場中佔據了相當大的收入份額。癌症和慢性病患病率的上升預計將推動對診斷測試的強勁需求,推動對分析儀器產品(如用於臨床測試的流式細胞儀)的需求。此外,臨床實驗室新分析儀器的批准和引進預計將推動該領域的增長。這使得快速、廉價和準確地識別樣品成為可能。
區域展望
按地區劃分,對北美、歐洲、亞太地區和 LAMEA 的分析儀器市場進行了分析。2021 年,北美市場在分析儀器市場的收入份額最高。這一巨大的市場份額歸功於該地區完善的製藥行業和醫療保健系統,對臨床和研究應用的分析儀器產生了巨大的需求。此外,大量旨在開發針對各種疾病的疫苗和藥物的研發項目,以及公共和私營部門對癌症研究的廣泛支持,也刺激了對分析和測量儀器的需求。我在玩
市場進入者採取的主要策略是“收購”。根據發表在 Cardinal Matrix 上的分析,F. Hoffmann-La Roche Ltd.、Thermo Fisher Scientific Inc. 和 Danaher Corporation 在分析儀器市場處於領先地位。Bio-Rad Laboratories, Inc.、Carl Zeiss AG 和 Agilent Technologies, Inc. 等公司是分析儀器市場的領先創新者。
The Global Analytical Instrumentation Market size is expected to reach $66.4 billion by 2028, rising at a market growth of 4.0% CAGR during the forecast period.
Analytical instrumentation is laboratory equipment used to investigate the separation, identification, and quantification of chemical components in both natural and synthetic materials. These analytical tools are employed to gather quantitative and qualitative data regarding the existence of a number of components in a particular sample. These tools are also used in a wide range of clinical diagnostic procedures as well as life sciences research to create new therapeutic and diagnostic products.
Pharmaceutical and biotechnology sectors have emerged as the leading end-users of analytical equipment due to their significant usage of these tools throughout the drug development process as a result of their vast R&D activities. Pharmaceutical enterprises are actively engaging and investing in R&D for the development of advanced and efficient products. Consequently, increased R&D investments and instrument adoption rates are likely to drive market growth.
In addition, enterprises are developing innovative technologies to fulfil expanding demand and exploit untapped market potential, which is being driven by the technological advancement of analytical instrumentation. Additionally, the use of analytical instrumentation solutions is anticipated to increase due to the growing development of precision medicine. In order to identify illnesses and create customized therapies, precision medicine utilizes analytical instrumentation for next-generation sequencing, molecular imaging, molecular dynamics, and molecular diagnostics.
For example, genomic sequencing is used in molecular diagnostics to analyze a patient's biomarkers. These tests carried out with different analytical tools, provide knowledge on the optimal course of action or even forecast the treatments that are most appropriate for a specific patient. Additionally, the 3D structures of biological organisms like proteins are widely studied using microscopes and techniques like cryogenic electron microscopy in the drug development process.
COVID-19 Impact Analysis
The COVID-19 pandemic caused a decline in the business of analytical instruments, including heat analyzers, spectroscopy, and chromatography-related equipment. This was brought on by the implementation of severe lockdown regulations, the interruption of supply networks, and a decline in clinical trial activity during that time. However, the pandemic caused a huge increase in demand for PCR, microarray, and sequencing technology-related instruments in 2021. Several novel PCR products were introduced during this time to address the rising COVID-19 cases. Problems like late product delivery along with an uneven demand for goods, hampered the supply chain of the analytical instruments industry.
Market Growth Factors
Rapid advancement in the development of precision medicine
This has propelled significant improvements in precision diagnoses and therapeutics as well as developments like next generation sequencing (NGS) and large genomic data. Additionally, there have been significant developments in gene therapy and the creation of precision medicines to treat ailments like cancer, TB, and Alzheimer's. As a result, more pharmaceutical and biotech businesses are starting to enter this market. Therefore, the growth of the analytical instrumentation market is being booted by the rise of precision medicine, providing individualized medicines and treatments.
Increasing usage of analytical instrumentation in water and wastewater treatment
Water and wastewater involve many processes, like chromatography. Therefore, the chromatography sector's development is driven by the incorporation of cutting-edge technologies like Big Data and artificial intelligence (AI). Such technologies are anticipated to automate the categorization of data and enhance the reliability of quantitative results due to the large amount of data generated during chromatography. Therefore, the requirement of analytical instrumentation in different R&D activities mainly to evaluate the characteristics and parameters of water & wastewater treatment is accelerating the market growth.
Market Restraining Factors
Dearth of skilled professionals to operate analytical equipment
The complexity of analytical instruments has significantly risen due to technological improvements, making it necessary to have a skilled crew handle them efficiently. Another significant obstacle is the lack of supporting infrastructure to establish testing facilities. Due to the fragmentation and predominance of small businesses in the manufacturing industry, sample collection from these businesses might be difficult for testing service providers in many developing nations. Lack of institutional cooperation and equipment shortage are two other significant problems. As a result, the lack of qualified specialists will probably limit how widely laboratory instruments and consumables are used by end users, thus slowing the market's growth.
Product Outlook
Based on product, the analytical instrumentation market is categorized into instruments, services, and software. The software segment procured a considerable growth rate in the analytical instrumentation market in 2021. Software is frequently utilized in various contexts, including academic research and clinical diagnosis, for data processing and result interpretation in analytical operations. For instance, with the help of flow cytometry software data is acquired & controlled, after which the results are statistical analysis is done. Over the course of the projected period, such software abilities are expected to fuel segment expansion.
Technology Outlook
On the basis of technology, the analytical instrumentation market is divided into polymerase chain reaction, spectroscopy, microscopy, chromatography, flow cytometry, sequencing, microarray, and others. The chromatography segment recorded a significant revenue share in the analytical instrumentation market in 2021. The diverse applications in life science, pharmaceutical, and other areas are mostly accountable for the segment's rise. The three types of chromatography are gas, liquid, and ion. Complex proteomic studies are discovered using liquid chromatography. Ion chromatography techniques are employed in fields where quality control is necessary like environmental testing.
Application Outlook
Based on application, the analytical instrumentation market is segmented into life sciences research & development, clinical & diagnostic analysis, food & beverage analysis, forensic analysis, environmental testing, and others. The clinical & diagnostic analysis segment acquired a substantial revenue share in the analytical instrumentation market in 2021. There is a strong demand for diagnostic tests due to the rising prevalence of cancer and chronic diseases, which is projected to fuel demand for analytical equipment goods like flow cytometers for clinical testing. Additionally, it is projected that the approval and introduction of novel analytical apparatus for clinical laboratories will accelerate segment growth. This makes it possible to identify samples quickly, cheaply, and accurately.
Regional Outlook
On the basis of region, the analytical instrumentation market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the highest revenue share in the analytical instrumentation market in 2021. This considerable market share can be due to the region's established pharmaceutical sector and healthcare system, which have generated a sizable demand for analytical instruments for clinical and research applications. The need for analytical instruments and instrumentation have also been spurred by high number of R&D projects that aim to develop vaccines and medicines for different diseases and by engaging more public-private support in cancer research.
The major strategies followed by the market participants are Acquisition. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc. and Danaher Corporation are the forerunners in the Analytical Instrumentation Market. Companies such as Bio-Rad Laboratories, Inc., Carl Zeiss AG, and Agilent Technologies, Inc. are some of the key innovators in Analytical Instrumentation Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Carl Zeiss AG, Danaher Corporation, Bruker Corporation, F. Hoffmann-La Roche Ltd., and Mettler-Toledo International, Inc.
Recent Strategies Deployed in Analytical Instrumentation Market
Mergers & Acquisition
Jan-2023: Thermo Fisher Scientific Inc. took over The Binding Site Group, a global leader in specialty diagnostics. Through this acquisition, Thermo Fisher Scientific Inc. would be able to extend its current specialty diagnostics portfolio along with pioneering innovation in monitoring and diagnostics for numerous myelomas.
Jan-2023: Carl Zeiss AG took over LENSO Sp. Z.o.o, a company that works in the field of servicing manufacturing companies in the field of precise industrial metrology. Through this acquisition, Carl Zeiss AG would be able to provide a fluent and combined experience to get the finest measuring solutions for the specific applications for its customers.
Mar-2022: Thermo Fisher Scientific, Inc., acquired Max Analytical Technologies, a producer of FTIR-based gas analysis solutions for process monitoring, source testing, and ambient air monitoring. Through this acquisition, Thermo Fisher Scientific, Inc., would be able to complete and extend its Software, FTIR instrument, and service offerings. Moreover, this acquisition would aid Thermo Fisher Scientific, Inc., to grow the range of vibrational spectroscopy services and solutions across a spectrum of market segments.
Feb-2022: Agilent Technologies Inc., took over Virtual Control's Advanced Artificial Intelligence (AI) Technology. Through this acquisition, Agilent Technologies Inc. would be able to combine the software into its industry-leading gas mass spectrometry and chromatography (GS/MS) platforms to enhance the efficiency, accuracy, and productivity of high-throughput labs.
Jun-2020: Illumina, Inc. took over BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. Through this acquisition, Illumina, Inc. would be able to combine BlueBee's abilities into its cloud portfolio which would further provide users the flexibility to operate their custom analyses or access industry-leading options. Moreover, this would lead to the most efficient, extensible, and scalable genomic analysis solutions for both translational and clinical research use cases.
Apr-2020: Bio-Rad Laboratories, Inc. took over Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Through this acquisition, Bio-Rad Laboratories, Inc. would expand its spread into the fast-growing world of single-cell analysis and precision medicine, both of which contribute to an improved understanding of diagnosis, treatment, and disease with the help of Celsee's technologies and products.
Aug-2019: Agilent Technologies, Inc., took over BioTek Instruments, a global leader in the design, manufacture, and distribution of innovative life science instrumentation. Through this acquisition, Agilent Technologies, Inc. would be able to extend its growing existence and expertise in cell analysis. Moreover, this would strengthen the company's standing in the growing and immense immunotherapy and immuno-oncology areas.
May-2018: PerkinElmer, Inc. took over Shanghai Spectrum Instruments Co., Ltd, one of the leading manufacturers of analytical instruments in China. Through this acquisition, PerkinElmer, Inc. intends to construct SSI's manufacturing capabilities and R&D in China to supply continuous software and hardware creations for its customers and support China's purpose of strengthening local manufacturing.
Mar-2018: Agilent Technologies Inc., acquired Advanced Analytical Technologies, Inc., a provider of capillary electrophoresis-based (CE) solutions for the fully-automated analysis of a range of molecules. Through this acquisition, Agilent Technologies Inc. would be able to improve its current technology and expertise while providing customers with a better complete group of solutions.
Product Launch and Product Expansions
Sep-2022: Perkinelmer, Inc. launched Dubbed Cellaca PLX Image Cytometry System. The new platform enables researchers to assess various critical quality attributes of cell samples, including quality, quantity, and identity of cells, in one automated workflow.
Sep-2022: PerkinElmer, Inc. unveiled Cellaca PLX Image Cytometry System. This new product allows researchers to evaluate multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including Quality, Quantity, and Cell Identity. Additionally, the Cellaca PLX integrates superior image cytometer software, hardware, trackable data, and validated consumables reporting all in one system without needing intense training requirements or complex calibration procedures.
Jun-2022: Agilent Technologies, Inc., launched new LC/MS and GC/MS quadrupole mass spectrometers. The new GC/TQ and LC/TQ products propose built-in instrument intelligence to streamline lab operations. Additionally, the new GC/TQ and GC/SQ products with the HydroInert source aid customers overcome key performance challenges with hydrogen carrier gas.
Feb-2022: Thermo Fisher Scientific Inc., launched a new portfolio of Chromatography and Mass Spectrometry consumables. This new product is crafted to fulfill higher performance needs while staying economical. Additionally, a new collection of vials, kits, caps, inserts, mats, and well plates would further enhance sample security and analytical performance for mass spectrometry and chromatography users in research and routine laboratories.
Mar-2020: Thermo Fisher Scientific Inc., unveiled the new Thermo Scientific Vanquish Core HPLC Systems. This new product would be able to extend the performance of the Vanquish platform to deliver a productivity-enhancing solution for routine laboratories.
Partnerships, Collaborations & Agreements
Jun-2021: Bio-Rad Laboratories, Inc. partnered with Seegene, Inc., a global leader in multiplex molecular diagnostics. Through this partnership, Bio-Rad Laboratories, Inc. would be able to use the diagnostic tests offered by Seegene, Inc. for its CFX96™ Dx Real-Time PCR System for clearance from The U.S. Food & Drug Administration (FDA) and U.S. markets pending clinical development.
Sep-2019: Thermo Fisher Scientific, Inc., came into collaboration with Cedars-Sinai, a leading nonprofit academic healthcare organization. Under this collaboration, Thermo Fisher Scientific, Inc., would target to deliver clinical research laboratories with sensitive and specific LC-MS-based workflows that would further provide improved confidence in data while witnessing and examining novel or comprehended protein-based biomarkers within biological matrices.
Market Segments covered in the Report:
By Product
By Technology
by Application
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures